Codes / ICD10CM / E09.52

E09.52 Drug or chemical induced diabetes mellitus with diabetic peripheral angiopathy with gangrene

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Drug or Chemical Induced Diabetes Mellitus with Diabetic Peripheral Angiopathy with Gangrene (ICD-10 Code: E09.52)

Summary

Drug or chemical induced diabetes mellitus with diabetic peripheral angiopathy with gangrene is a condition where elevated blood sugar levels, caused by exposure to specific medications or chemicals, lead to damage to the peripheral blood vessels and the development of gangrene. This form of diabetes is directly attributable to external factors that disrupt glucose metabolism, resulting in hyperglycemia and associated vascular complications affecting the extremities, including tissue death due to reduced blood flow.

Causes

The condition is caused by exposure to drugs or chemicals that impair glucose regulation, leading to uncontrolled hyperglycemia and subsequent peripheral vascular damage. Common culprits include medications (e.g., glucocorticoids, antipsychotics, or diuretics) and toxins that reduce insulin secretion or increase insulin resistance. These substances trigger hyperglycemia, which, if untreated, progresses to peripheral angiopathy and gangrene due to prolonged elevated blood sugar affecting blood vessels in the limbs.

Risk Factors

  • Use of medications known to affect glucose metabolism (e.g., steroids, antiretrovirals).
  • Exposure to chemicals or toxins that disrupt endocrine function.
  • Pre-existing metabolic conditions that increase susceptibility to drug-induced effects.
  • Dosage and duration of exposure to the causative agent.
  • Poorly controlled blood sugar levels.
  • History of peripheral vascular disease.

Symptoms

  • Severe pain or numbness in the extremities.
  • Non-healing ulcers or sores on the feet or legs.
  • Discoloration of the skin (e.g., black or blue areas indicating tissue death).
  • Foul-smelling discharge from affected areas.
  • Fever or chills, indicating infection.
  • Reduced sensation or tingling in the affected limbs.

Diagnosis

Diagnosis involves a combination of clinical evaluation, laboratory tests, and imaging studies. Blood tests to measure glucose levels and assess glycemic control are essential. Imaging, such as Doppler ultrasound or angiography, may be used to evaluate blood flow in the peripheral vessels. Tissue samples from gangrenous areas may be analyzed to rule out infection or other causes. A thorough review of medication and chemical exposure history is critical to confirm the drug or chemical-induced etiology.

Treatment Options

Treatment focuses on managing hyperglycemia, improving blood flow, and addressing gangrene. This may include discontinuing the causative agent, if possible, and initiating antidiabetic medications or insulin therapy. Antibiotics are used to treat or prevent infection. In severe cases, surgical intervention, such as debridement or amputation, may be necessary to remove dead tissue. Revascularization procedures, like angioplasty or bypass surgery, may be considered to restore blood flow.

Prognosis and Follow-Up

Prognosis depends on the extent of tissue damage, timely intervention, and management of underlying hyperglycemia. Early treatment can improve outcomes and prevent further complications. Regular follow-up is essential to monitor blood sugar levels, assess wound healing, and adjust treatment as needed. Long-term management includes lifestyle modifications and ongoing medical care to control diabetes and prevent recurrence.

Complications

  • Progressive tissue death and potential amputation.
  • Severe infection, including sepsis.
  • Chronic pain or disability.
  • Increased risk of cardiovascular events.
  • Delayed wound healing.
  • Recurrence of gangrene if hyperglycemia is not controlled.

Lifestyle & Prevention

  • Avoid or discontinue exposure to known causative drugs or chemicals, when medically appropriate.
  • Maintain strict blood sugar control through diet, exercise, and medication.
  • Practice good foot care, including regular inspections and proper hygiene.
  • Quit smoking, as it worsens peripheral vascular disease.
  • Manage other risk factors, such as high blood pressure or cholesterol.

When to Seek Professional Help

Seek immediate medical attention if you experience:

  • Sudden or worsening pain in the extremities.
  • New or worsening sores that do not heal.
  • Changes in skin color (e.g., blackening or discoloration) on the feet or legs.
  • Signs of infection, such as fever, chills, or foul-smelling discharge.
  • Numbness or loss of sensation in the limbs.

Tips for Medical Coders

When coding for E09.52, ensure documentation clearly links the diabetes to drug or chemical exposure and specifies the presence of diabetic peripheral angiopathy with gangrene. Verify that the gangrene is attributed to the peripheral angiopathy and not another cause. Include details about the causative agent, if known, and any relevant clinical findings to support the diagnosis. Accurate coding requires distinguishing this condition from other forms of diabetes or gangrene not induced by drugs or chemicals.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

E09.52 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.